FDA
approval
· 2020-07-31
FDA Approved: EVOTAZ — Supplemental Application (E.R. Squibb & Sons, L.L.C.)
Summary
The FDA approved a supplemental application for EVOTAZ (atazanavir and cobicistat) from E.R. Squibb & Sons, L.L.C. The action pertains to the approval of the su…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for EVOTAZ (ATAZANAVIR AND COBICISTAT)